このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

パーキンソン病に対する自然に基づく治療プログラム (PARC) (PARC)

2026年11月2日 更新者:Rubens da Silva、Université du Québec à Chicoutimi

Nature-based Therapy Program for Sustainable Health in Parkinson's Disease (PARC Project) - A Clinical Trial

The goal of this clinical trial is first to determine the feasibility and to learn if a nature-based program has positive effects on the physical and psychosocial health in a group of participants with Parkinson's disease. The main questions for this purpose are:

Will the program improve:

  • The physical outcomes such as mobility, strength and balance?
  • The psychosocial health outcomes?

Participants will participate in one session per week of the intervention and be assessed before and after the program. First, the adherence will be measured as the proportion of supervised outdoor sessions completed. Dropout rate will correspond to participants who will not finish the 8-week protocol, including pre- and post-intervention assessments. Satisfaction will be evaluated with a post-intervention questionnaire rating the exercise component, nature-based activities, and the PARC program on a 4-point Likert scale (0-3), capturing clarity, usefulness, difficulty, and acceptability. Adverse effects will be documented throughout the intervention. Qualitative benefits such as increased hope and improved social interaction will be collected after sessions.

調査の概要

詳細な説明

The chronic and neurodegenerative disease of Parkinson's (PD) is often characterized by movement and balance disorders, which are accompanied by an increased risk of falls. Falls are one of the most common problems that can lead to subsequent injuries (e.g., femoral head fracture) and associated mortality rates. Falls are frequent, debilitating, and have deleterious effects on self-confidence and the quality of life of individuals with PD. Additionally, according to Parkinson Canada, a high proportion of individuals living with this disease suffer from depression and/or anxiety. Therefore, it is essential to implement intervention programs aimed at improving the physical and functional capacity as well as the well-being of this population to prevent falls and promote sustainable health.

In recent years, an increasing number of studies have demonstrated the benefits of contact with nature on the physical and mental health of individuals. Specific and positive effects on psychological symptoms (e.g., depression) as well as cognition (memory) in adults have also been shown according to this recent evidence. This stimulates our research team to test the effects of a physical intervention in nature on the physical and mental health of individuals suffering from PD. One of the perspectives of this new intervention in nature is also to evaluate its impact on fall risks in this population. The ultimate goal of this project is to contribute to the sustainable health of the population.

The overall objective of this project, based on a pilot study, is to assess the feasibility and the effects of an 8-week nature-based intervention program on the physical and mental health of individuals with PD. The feasibility indicators are:

Adherence - proportion of supervised outdoor sessions that will be completed by participants; Dropout Rate - proportion of participants who will not complete the full 8-week protocol, including pre- and post-intervention assessments; Satisfaction - participant satisfaction will be measured with a brief post-intervention questionnaire using a 4-point Likert scale assessing clarity, usefulness, difficulty, and acceptability of the NBI/PARC program; Adverse Effects - any adverse events will be documented throughout the intervention; and Perceived Benefits - qualitative feedback will be collected on perceived benefits such as increased hope and improved social interaction. In addition, various physical measures (mobility, strength, and balance) and mental measures (level of depression, stress) will be studied in this project to better understand the effects of this type of intervention.

研究の種類

介入

入学 (実際)

11

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Quebec
      • Saguenay、Quebec、カナダ、G7H 2B1
        • Rubens da Silva

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

45年~85年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • diagnosed with Parkinson's disease (while medicated: ON);
  • capable of walking independently;
  • presenting mild to moderate disability symptoms according to the Hoehn and Yahr scale (stages 1-3);
  • having a frailty score of less than 2/5 (Fried);
  • having a cognitive status ≥26 based on the Mini-Mental State Examination (MMSE) questionnaire.

Exclusion Criteria:

  • Cancer;
  • Red flags (infection, tumor, etc.);
  • Severe psychiatric disorders;
  • Palliative care;
  • Severe systemic syndromes or diseases that may prevent tests and exercises from being performed;
  • Stroke - very acute phase (1 week) and this until medial hemodynamic stability.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Nature-based intervention

Nature-based group intervention of once a week for 8 weeks

Activities in nature such as walking, exercises (strengthening, mobility, balance), pedal boat, yoga, dance, mindfulness, meditation, forest bathing or Shinrin-Yoku, interpretation of nature

他の名前:
  • 自然に基づいたセラピー

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Depression state (PHQ-9)
時間枠:change from baseline at 0 to 8 weeks

The Patient Health Questionnaire-9 (PHQ-9) is a self-administered tool used to screen, diagnose, monitor, and measure the severity of depression. It consists of nine questions based on the diagnostic criteria for major depressive disorder in the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition).Respondents rate how often they have experienced each symptom over the past two weeks on a scale ranging from 0 (not at all) to 3 (nearly every day). The scores are then added together to produce a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms

change from baseline at 0 to 8 weeks
Retention rate
時間枠:8 weeks

roportion of participants completing the full 8-week protocol including pre- and post-intervention assessments.

8 weeks
Adherence to supervised outdoor sessions
時間枠:8 weeks

Proportion of scheduled supervised outdoor sessions completed by each participant.

8 weeks
Dropout rate
時間枠:8 weeks

Proportion of participants who discontinue participation before completing the protocol.

8 weeks
Participant satisfaction
時間枠:Post-intervention

Participant Satisfaction was measured using the "Participant Satisfaction Likert Scale", a 4-point scale ranging from 0 (strongly disagree) to 3 (strongly agree). Higher scores indicate greater satisfaction with the intervention, including clarity of instructions, perceived usefulness, exercise difficulty, and overall acceptability.

Post-intervention
Adverse effects
時間枠:8 weeks

Number and type of adverse events reported during the intervention.

8 weeks
Qualitative feedback on perceived benefits
時間枠:through study completion, an average of 8 weeks.

Qualitative feedback collected after each session through brief open-ended questions documenting perceived benefits such as increased hope, enhanced social interaction, and other emergent themes.

through study completion, an average of 8 weeks.
Well-being state (WHO-5)
時間枠:change from baseline at 0 to 8 weeks

The World Health Organization Well-Being Index (WHO-5) is a widely used self-reported questionnaire designed to measure subjective well-being. It assesses the individual's overall psychological well-being and quality of life. The WHO-5 consists of five simple questions that ask respondents to rate their well-being over the past two weeks. The questions cover aspects such as positive mood, vitality, and general interest in life.

The questionnaire is scored on a scale from 0 to 100, with higher scores indicating better well-being.

change from baseline at 0 to 8 weeks
Social Provisions (SPS-10)
時間枠:change from baseline at 0 to 8 weeks

The Social Provisions Scale-10 (SPS-10) is a shorter version of the original Social Provisions Scale (SPS). It is a brief self-report questionnaire designed to measure perceived social support across five dimensions. The SPS-10 is derived from the longer SPS but consists of a subset of items that capture key aspects of social support.

Similar to the original SPS, respondents rate their agreement with each item on a Likert scale, ranging from 1 (strongly disagree) to 4 (strongly agree). The SPS-10 provides a quick and efficient way to assess an individual's perceived social support network and their satisfaction with various aspects of their social relationships.

change from baseline at 0 to 8 weeks
Connection to nature (CNS)
時間枠:change from baseline at 0 to 8 weeks

The Connection to Nature Scale (CNS) is a psychological assessment tool designed to measure an individual's subjective connection to nature. It evaluates the degree to which people perceive themselves as a part of the natural world and the extent to which they appreciate and value nature in their lives.

Respondents are asked to rate their agreement with each statement on a Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). The scores are then totaled to provide an overall measure of an individual's connection to nature.

change from baseline at 0 to 8 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Functional mobility test (TUG)
時間枠:change from baseline at 0 to 8 weeks

To assess mobility. Equipment: A stopwatch. Directions: Patients wear their regular footwear and can use a walking aid, if needed. Begin by having the patient sit back in a standard arm chair and identify a line 3 meters, or 10 feet away, on the floor.

change from baseline at 0 to 8 weeks
5 times Sit-To-Stand (FTSTS)
時間枠:change from baseline at 0 to 8 weeks

f the 30 second sit to stand test was not applied for some patients, we used also this test which it measures the amount of time it takes for a patient to sit and stand five times in succession with arms folded across their chest. 2 trials were applied in this test and the best time in seconds used for analysis.

change from baseline at 0 to 8 weeks
Maximal isometric hand grip strength
時間枠:change from baseline at 0 to 8 weeks

Jamar dynamometer to assess maximal isometric hand grip strength and frailty criteria. 3 trials of maximal contraction up 5 seconds. The best value was retained and corrected by body mass index from Fried classification.

change from baseline at 0 to 8 weeks
Postural control
時間枠:change from baseline at 0 to 8 weeks

Measures of center of pressure (COP) from plateform of force during different balance tasks

change from baseline at 0 to 8 weeks
Walking pattern
時間枠:change from baseline at 0 to 8 weeks

Gait parameters from GaitRite system (14-ft walkway) measurement across two speeds: preferred and fast, with a sampling frequency of 100 Hz.

change from baseline at 0 to 8 weeks
10 m walk test
時間枠:change from baseline at 0 to 8 weeks

The test was performed along a 14 m walkway, with timing initiated at the 2 m mark and stopped at the 12 m mark to ensure steady state walking. Each participant completed two trials at both comfortable (preferred) and maximal walking (fast) speeds, and the best time for each condition was retained for analysis.

change from baseline at 0 to 8 weeks

その他の成果指標

結果測定
メジャーの説明
時間枠
Modified Falls Efficacy Scale (M FES)
時間枠:change from baseline at 0 to 8 weeks

The confidence in performing daily activities without falling was evaluated using the French version of the Modified Falls Efficacy Scale (M FES), consisting of 14 items rated from 0 (no confidence) to 10 (complete confidence), with higher scores indicating greater falls related self efficacy.

change from baseline at 0 to 8 weeks
Frailty criteria from Fried (inclusion criterium only)
時間枠:change from baseline at 0 to 8 weeks

The presence of frailty criteria according to Fried was assessed with self-report questions and two physical tests from five characteristics : 1) Low physical activity (to capture history of sedentary behavior or activity: ex. Do you get any physical exercise for the sake of exercising? How often do you leave your house?); 2) fatigue (complaint of exhaustion with normal activity such as walking outside, climbing stairs: ex. I felt that everything I did was an effort in the last week?); 3) weight loss (unintentional weight loss 10 lbs. or more in past year or more than 5% in past year); 4) weakness (grip strength evaluated with manual dynamometer; in average <30 kg for men and <18 kg for women, but data is normalized by body mass index); 5) slowness or slow walking speed (usual gait speed over 4.57 meters (15 feet); ex. >6.5 seconds, dependent of height).

change from baseline at 0 to 8 weeks
Hoehn and Yahr Scale
時間枠:Only at baseline from Sample characterization when Parkinson was included

It is a five-point scale used by doctors and researchers to rate the degree of disability and severity of symptoms caused by Parkinson's disease:

Stage 1: Unilateral involvement only Stage 1.5: Unilateral and axial involvement Stage 2: Bilateral involvement without impairment of balance Stage 2.5: Mild bilateral disease with recovery on pull test Stage 3: Mild to moderate bilateral disease; some postural instability; physically independent Stage 4: Severe disability; still able to walk or stand unassisted Stage 5: Wheelchair bound or bedridden unless aided

Only at baseline from Sample characterization when Parkinson was included
Cognitive status
時間枠:Only at baseline from Sample characterization

Mini-mental state questionnaire (MMSE or Folstein), which is used for grading the cognitive state of patients in this study. It's assessing the attention and orientation, memory, registration, recall, calculation, language and ability to draw a complex polygon.

It is ranged from 0 to 30, where 30 means no impairment.

Only at baseline from Sample characterization

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • スタディチェア:Marie-Ève Langelier, MD、Université du Québec à Chicoutimi
  • 主任研究者:Rubens da Silva, PhD、Université du Québec à Chicoutimi
  • スタディチェア:Émilie Fortin, PT、Université du Québec à Chicoutimi
  • スタディチェア:Mireille Cliche, SW、Université du Québec à Chicoutimi

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年8月5日

一次修了 (実際)

2024年10月7日

研究の完了 (実際)

2024年10月7日

試験登録日

最初に提出

2024年5月22日

QC基準を満たした最初の提出物

2024年6月4日

最初の投稿 (実際)

2024年6月11日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月5日

QC基準を満たした最後の更新が送信されました

2026年11月2日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する